Publications: Autoimmune diseases (5)


Sagard J, Olofsson T, Mogard E, Marsal J, Andréasson K, Geijer M, Kristensen LE, Lindqvist E, Wallman JK. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis - PubMed ( Arthritis Res Ther. 2022 Feb 12;24(1):42. doi: 10.1186/s13075-022-02733-w. PMID: 35151357; PMCID: PMC8840679.


Andréasson K, Neringer K, Wuttge DM, Henrohn D, Marsal J, Hesselstrand R. Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study - PubMed ( Arthritis Res Ther. 2020 Oct 6;22(1):230. doi: 10.1186/s13075-020-02323-8. PMID: 33023643; PMCID: PMC7539387.


Klingberg E, Magnusson MK, Strid H, et al. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin - PubMed ( Arthritis Res Ther. 2019;21(1):248. Published 2019 Nov 27.


Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity - PubMed ( Arthritis Res Ther. 2017;19(1):237. Published 2017 Oct 24.


Andréasson K, Alrawi Z, Persson A, Jönsson G, Marsal J. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease - PubMed ( Arthritis Res Ther. 2016;18(1):278. Published 2016 Nov 29.